EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Scalable multimodal weak anion exchange chromatographic purification for stable mRNA drug substance

Polona Megušar, Rok Miklavčič, Matevž Korenč, Jure Ličen, Tina Vodopivec, Urh Černigoj iD, Aleš Štrancar, Rok Sekirnik iD

ELECTROPHORESIS · 2023-12 · 44 (24) · 1978-1988

DOI: 10.1002/elps.202300106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ELECTROPHORESIS, online erschienen am 12.10.2023. Verfasst von Polona Megušar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sartorius BIA Separations d.o.o., Ajdovščina, Slovenia. Hauptthemen laut MEDLINE: RNA, Circular, RNA. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Innovation Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Messenger RNA (mRNA) has emerged as a modality with immense therapeutic potential. Recent innovations in production process of mRNA call for procedures to isolate pure mRNA drug substance (DS) with high yield, high capacity, scalability, and compatibility with GMP production systems. Novel RNA modalities, such as circular RNA (circRNA), have further driven the need for non‐affinity capture possibilities which are already widely used in the biopharmaceutical industry, for example, in monoclonal antibody processing. The principle that multimodal ion exchange/hydrogen bonding chromatography can be used to separate mRNA from in vitro transcription components has recently been demonstrated. Here, we apply and refine this approach to be suitable for scalable purification of multiple mRNA constructs with sufficient yields, purity, and stability, for use in mRNA production process. Binding capacity of the PrimaS‐modified monolithic chromatographic column for mRNA enabled up to 7 mg/mL product isolation in a single chromatographic run, with 98% recovery and room temperature stability of the eGFP mRNA demonstrated for up to 28 days. This approach is independent of construct size or the presence of polyadenylic acid tail and is applicable for capture of a wide variety of RNAs, including mRNA, self‐amplifying RNA, circRNA, and with optimization also smaller RNAs such as transfer RNA and others.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, CircularRNARNA, MessengerChromatography, Ion ExchangeAnions

Stichwörter der Autor:innen

chromatographyhigh-performance liquid chromatographyin vitro transcriptionmRNAphosphate

Substanzen

RNA, MessengerRNA, CircularRNAAnions

Autor:innen und Institutionen

  • Sartorius BIA Separations d.o.o., Ajdovščina, Slovenia.

ORCID-Profile: Urh Černigoj, Rok Sekirnik

Förderung

  • European Innovation Council

Zitieren

APA

Megušar, P., Miklavčič, R., Korenč, M., Ličen, J., Vodopivec, T., Černigoj, U., Štrancar, A., & Sekirnik, R. (2023). Scalable multimodal weak anion exchange chromatographic purification for stable mRNA drug substance. ELECTROPHORESIS, 44(24), 1978-1988. https://doi.org/10.1002/elps.202300106

Vancouver

Megušar P, Miklavčič R, Korenč M, Ličen J, Vodopivec T, Černigoj U, et al. Scalable multimodal weak anion exchange chromatographic purification for stable mRNA drug substance. ELECTROPHORESIS. 2023;44(24):1978-1988. doi:10.1002/elps.202300106

BibTeX
@article{Meguar2023,
  author = {Megušar, Polona and Miklavčič, Rok and Korenč, Matevž and Ličen, Jure and Vodopivec, Tina and Černigoj, Urh and Štrancar, Aleš and Sekirnik, Rok},
  title = {Scalable multimodal weak anion exchange chromatographic purification for stable mRNA drug substance},
  journal = {ELECTROPHORESIS},
  year = {2023},
  volume = {44},
  number = {24},
  pages = {1978--1988},
  doi = {10.1002/elps.202300106}
}
Kostenlos starten →